Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.40    0.40 (0.26%)
Bid:
156.40
Ask:
156.80
Spread: 0.40 (0.256%)
Market Cap: £894.25m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

FORM 8.3 - ELEMENTIS PLC

27 Nov 2020 12:31

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a)Full name of discloser:Barclays PLC.
 
(b)Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c)Name of offeror/offeree in relation to whoseELEMENTIS PLC
relevant securities this form relates:
(d)If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e)Date position held/dealing undertaken:26 November 2020
(f)In addition to the company in 1(c) above, is the discloser makingNO
disclosures in respect of any other party to the offer?

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:5p ordinary
InterestsShort Positions
Number(%)Number(%)

(1)

Relevant securities owned
and/or controlled:

10,195,962

1.76%

2,577,753

0.44%

 

 

 

 

(2)

Cash-settled derivatives:

 

 

 

 

2,077,189

0.36%

7,245,290

1.25%

 

 

 

 

(3)

Stock-settled derivatives (including options)

 

 

 

 

and agreements to purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

TOTAL:

12,273,151

2.11%

9,823,043

1.69%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

5p ordinary

Purchase

463

1.1350 GBP

5p ordinary

Purchase

815

1.1420 GBP

5p ordinary

Purchase

1,867

1.1405 GBP

5p ordinary

Purchase

2,057

1.1260 GBP

5p ordinary

Purchase

2,395

1.1265 GBP

5p ordinary

Purchase

2,670

1.1324 GBP

5p ordinary

Purchase

3,149

1.1430 GBP

5p ordinary

Purchase

5,469

1.1352 GBP

5p ordinary

Purchase

6,521

1.1402 GBP

5p ordinary

Purchase

6,731

1.1459 GBP

5p ordinary

Purchase

10,936

1.1339 GBP

5p ordinary

Purchase

12,699

1.1498 GBP

5p ordinary

Purchase

28,028

1.1300 GBP

5p ordinary

Purchase

34,893

1.1437 GBP

5p ordinary

Purchase

35,777

1.1282 GBP

5p ordinary

Purchase

58,826

1.1329 GBP

5p ordinary

Purchase

80,035

1.1359 GBP

5p ordinary

Sale

813

1.1265 GBP

5p ordinary

Sale

1,709

1.1275 GBP

5p ordinary

Sale

2,311

1.1301 GBP

5p ordinary

Sale

5,176

1.1260 GBP

5p ordinary

Sale

7,778

1.1225 GBP

5p ordinary

Sale

9,690

1.1446 GBP

5p ordinary

Sale

10,670

1.1289 GBP

5p ordinary

Sale

15,098

1.1283 GBP

5p ordinary

Sale

16,672

1.1500 GBP

5p ordinary

Sale

43,710

1.1410 GBP

5p ordinary

Sale

49,362

1.1312 GBP

5p ordinary

Sale

107,913

1.1322 GBP

5p ordinary

Sale

261,046

1.1460 GBP

(b) Cash-settled derivative transactions

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

5p ordinary

SWAP

Long

1,021

1.1499 GBP

5p ordinary

SWAP

Long

16,518

1.1358 GBP

5p ordinary

SWAP

Long

82,949

1.1500 GBP

5p ordinary

SWAP

Long

89,067

1.1282 GBP

5p ordinary

CFD

Long

129,652

1.1499 GBP

5p ordinary

SWAP

Short

1,459

1.1353 GBP

5p ordinary

SWAP

Short

1,581

1.1345 GBP

5p ordinary

SWAP

Short

1,608

1.1372 GBP

5p ordinary

CFD

Short

2,067

1.1470 GBP

5p ordinary

SWAP

Short

4,676

1.1343 GBP

5p ordinary

CFD

Short

5,287

1.1301 GBP

5p ordinary

SWAP

Short

5,381

1.1231 GBP

5p ordinary

SWAP

Short

28,682

1.1376 GBP

5p ordinary

SWAP

Short

55,527

1.1349 GBP

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

27 Nov 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201127005355/en/

Copyright Business Wire 2020

Date   Source Headline
13th Nov 20209:47 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - ELEMENTIS PLC - Ordinary Shares
12th Nov 20209:39 amRNSResponse to Minerals Technologies Inc announcement
12th Nov 20207:51 amRNSStatement re Possible Offer
9th Nov 20204:55 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSQ3 Trading Update
26th Oct 20207:00 amRNSUpdate on 2020 AGM resolution vote
16th Oct 20207:00 amRNSDirectorate Change
17th Sep 202012:40 pmRNSDirector/PDMR Shareholding
7th Sep 20207:00 amRNSCovenant update
1st Sep 20202:22 pmRNSBlock listing Interim Review
28th Jul 20207:00 amRNSHalf-year Report
8th Jun 20204:28 pmRNSHolding(s) in Company
15th May 20201:08 pmRNSHolding(s) in Company
1st May 20209:56 amRNSTotal Voting Rights
29th Apr 202011:02 amRNSDirector Declaration
29th Apr 202010:49 amRNSResult of AGM
29th Apr 20207:00 amRNSAGM Trading Statement
28th Apr 202012:06 pmRNSDisclosure of rights attached to equity shares
21st Apr 20207:00 amRNSAGM update
8th Apr 202011:50 amRNSDirector/PDMR Shareholding
2nd Apr 20202:51 pmRNSHolding(s) in Company
1st Apr 20208:13 amRNSDirector Declaration
25th Mar 20204:04 pmRNSAnnual Financial Report
25th Mar 202010:19 amRNSHolding(s) in Company
24th Mar 20209:02 amRNSHolding(s) in Company
23rd Mar 20205:25 pmRNSHolding(s) in Company
20th Mar 20205:28 pmPRNDirector/PDMR Shareholding
20th Mar 20205:07 pmRNSDirector/PDMR Shareholding
20th Mar 20205:06 pmRNSDirector/PDMR Shareholding
20th Mar 202010:44 amRNSHolding(s) in Company
19th Mar 20204:28 pmRNSDirector/PDMR Shareholding
19th Mar 20204:25 pmRNSDirector/PDMR Shareholding
19th Mar 20204:24 pmRNSDirector/PDMR Shareholding
19th Mar 20207:00 amPRNCOVID-19 update
18th Mar 20203:14 pmRNSAdditional Listing
17th Mar 202010:25 amRNSDirector/PDMR Shareholding
12th Mar 202010:36 amRNSDirector/PDMR Shareholding
10th Mar 20202:02 pmRNSDirector/PDMR Shareholding
9th Mar 202010:57 amRNSDirector/PDMR Shareholding
6th Mar 20202:36 pmRNSDirector/PDMR Shareholding
6th Mar 20202:35 pmRNSDirector/PDMR Shareholding
5th Mar 20201:41 pmRNSDirector/PDMR Shareholding
4th Mar 20207:00 amRNS2019 Preliminary Results Announcement
2nd Mar 20203:46 pmRNSBlock listing Interim Review
2nd Mar 202011:22 amPRNTotal Voting Rights
4th Feb 20207:00 amRNSDirectorate Change
21st Jan 20208:46 amPRNDirector Declaration
20th Jan 202010:54 amPRNHolding(s) in Company
14th Jan 20207:00 amRNSTrading update
6th Jan 202010:09 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.